drugset / Trial / NCT06444035

Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome

NCT06444035

Unknown 10 enrolled Nakhia Impex LLC
NaSingle-groupOpen-labelTreatment

Summary

To verify the efficacy and safety of HA35 in chronic pain management and to further supplement effective treatments for chronic pain, we designed a proof-of-concept clinical study. This study aims to evaluate the 15-day treatment of HA35 on patients with myofascial pain syndrome and to observe the effects for up to 3 months.

Timeline

Start
2024-05-30
Primary completion
2024-10-30
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Hyaluronate Other / unclassified 100 mg Subcutaneous